Literature DB >> 9552581

Positive and negative regulation of angiogenesis: from cell biology to the clinic.

M S Pepper1.   

Abstract

Virtually every subspecialty in medicine in one way or another deals with angiogenesis-associated physiological or pathological processes and, without exception, every organ system in the body has many diseases in which angiogenesis is an important component. This in itself makes the study of angiogenesis mandatory, in both basic science and clinical settings. Yet the study of angiogenesis does not require this justification. As a biological process it is extraordinarily rich, touching on virtually every aspect of modern cell biology, making it almost impossible for molecular biologists, biochemists and morphologists to ignore. Considerable therapeutic benefit can now be obtained through positive or negative manipulation of the angiogenic process, and this is due in large part to the rapid transfer to the clinical setting of knowledge acquired through a cell biological approach.

Mesh:

Substances:

Year:  1996        PMID: 9552581     DOI: 10.1177/1358863X9600100404

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  4 in total

1.  Proteomic characterisation reveals active Wnt-signalling by human multipotent stromal cells as a key regulator of beta cell survival and proliferation.

Authors:  Miljan Kuljanin; Gillian I Bell; Stephen E Sherman; Gilles A Lajoie; David A Hess
Journal:  Diabetologia       Date:  2017-07-14       Impact factor: 10.122

Review 2.  Angiogenesis and antiangiogenic strategies in pancreatic cancer.

Authors:  William E Fisher; David H Berger
Journal:  Int J Gastrointest Cancer       Date:  2003

3.  Vitreous levels of vascular endothelial growth factor, stromal cell-derived factor-1α, and angiopoietin-like protein 2 in patients with active proliferative diabetic retinopathy.

Authors:  Ali Keles; Kenan Sonmez; Yasemin Ozdamar Erol; Sema Nur Ayyıldız; Elmas Ogus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-19       Impact factor: 3.117

4.  Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.

Authors:  Lei Liu; Michael B Boffa; Marlys L Koschinsky
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.